Company Overview: BELLUS Health Inc. (TO: BLU) is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. In August 2019, the company appointed Dr. Bonuccelli as the Chief Medical Officer, who has more than 20 years of significant expertise in clinical development of respiratory products.
Please wait processing your request...
CA
AU
UK
US
NZ